Bookmark and Share
formamide (CID 713) - Compound BioActivity Data
.
BioActivity Outcomes:
Inactive(330)
 
 
Inconclusive(10)
 
 
Unspecified(10)
 
 
Top Targets:
NR LBD PPAR(21)
 
 
 
NR LBD ER(16)
 
 
NR LBD AR(16)
 
 
NR LBD VDR(10)
 
 
NR LBD TR(10)
 
 
BioAssay Types:
Confirmatory(274)
 
 
 
Summary(48)
 
 
Literature(11)
 
 
 
BioActivity Types:
Potency(274)
 
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 252    Data Row: 350   Total Pages: 18   Display: Page     
Sort: [Click the result table header to sort]
#SubstanceActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID103168892]
Micelle/water partition coefficient (Pmic) of the compound was determined [AID23734, Type: Literature]
View
2
[SID103168892]
Antitumor activity was evaluated against the TLX5 lymphoma in mice measured for control as death day at a optimal doses of 800 mg/Kg/day [AID110030, Type: Literature]
View
3
[SID103168892]
Antitumor activity was evaluated against the M5076 reticulum cell sarcoma in mice measured as Control tumor volume for the treated at the optimal dose 200 mg/Kg/day [AID110147, Type: Literature]
View
4
[SID103168892]
Antitumor activity was evaluated against the M5076 reticulum cell sarcoma in mice at dose of 400-100 mg/kg per day [AID116704, Type: Literature]
View
5
[SID103168892]
Antitumor activity was evaluated against the M5076 reticulum cell sarcoma in mice at dose of 400-100 mg/kg per day [AID116888, Type: Literature]
View
6
[SID103168892]
Antitumor activity was evaluated against the M5076 reticulum cell sarcoma in mice measured as mean tumor volume for the treated at the optimal dose 200 mg/Kg/day [AID118234, Type: Literature]
View
7
[SID103168892]
Antitumor activity was evaluated against the TLX5 lymphoma measured as mean death day for the treated at a optimal dose of 800 mg/Kg/day [AID118240, Type: Literature]
View
8
[SID103168892]
Antitumor activity was evaluated against the TLX5 lymphoma in mice measured as treated to control at optimal dose. 800 mg/Kg/day [AID122264, Type: Literature]
View
9
[SID103168892]
Antitumor activity was evaluated for the compound against the M5076 reticulum cell sarcoma in mice and the % T/C(treated/control) value was calculated at optimal dose of 200 mg/kg [AID122376, Type: Literature]
View
10
[SID17388996]
qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways [AID651838, Type: other]
View
11
[SID144213141]
Potency-Replicate_1 13.8022qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway [AID743069, Type: confirmatory]estrogen nuclear receptor alpha [Homo sapiens] [gi:348019627]
View
12
[SID144213141]
Potency-Replicate_1 30.6379qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability [AID651634, Type: confirmatory]
View
13
[SID144209140]
Potency-Replicate_1 67.6516qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability [AID651634, Type: confirmatory]
View
14
[SID17388996]
Potency qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 1 hr assay [AID651754, Type: confirmatory]
View
15
[SID17388996]
Potency qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 5 hr assay [AID651755, Type: confirmatory]
View
16
[SID144209140]
Potency-Replicate_1 qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway [AID743212, Type: confirmatory]peroxisome proliferator-activated receptor delta [Homo sapiens] [gi:216409690]
View
17
[SID144213141]
Potency-Replicate_1 qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway [AID743212, Type: confirmatory]peroxisome proliferator-activated receptor delta [Homo sapiens] [gi:216409690]
View
18
[SID144209140]
Potency-Replicate_1 qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway [AID743215, Type: confirmatory]peroxisome proliferator-activated receptor delta [Homo sapiens] [gi:216409690]
View
19
[SID144209140]
qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary [AID743226, Type: summary]peroxisome proliferator-activated receptor delta [Homo sapiens] [gi:216409690]
View
20
[SID144213141]
qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary [AID743226, Type: summary]peroxisome proliferator-activated receptor delta [Homo sapiens] [gi:216409690]
View